Dova Pharmaceuticals PE Ratio 2017-2019 | DOVA

Current and historical p/e ratio for Dova Pharmaceuticals (DOVA) from 2017 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Dova Pharmaceuticals PE ratio as of July 15, 2019 is 0.00.
Dova Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-07-16 16.07 0.00
2019-03-31 8.89 $-2.66 0.00
2018-12-31 7.58 $-2.60 0.00
2018-09-30 20.97 $-2.27 0.00
2018-06-30 29.92 $-1.96 0.00
2018-03-31 27.12 $-1.58 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.453B $0.010B
Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.361B 34.73
Astellas Pharma (ALPMY) Japan $28.294B 13.87
Takeda Pharmaceutical (TAK) Japan $28.107B 8.25
Eisai (ESALY) Japan $16.062B 27.62
UCB SA (UCBJF) Belgium $15.866B 0.00
Grifols, S.A (GRFS) Spain $14.831B 18.76
Merck (MKGAF) Germany $13.435B 18.33
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Sage Therapeutics (SAGE) United States $9.586B 0.00
Ionis Pharmaceuticals (IONS) United States $9.522B 20.82
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.992B 0.00
Catalent (CTLT) United States $7.866B 31.57
Jazz Pharmaceuticals (JAZZ) Ireland $7.641B 10.48
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.789B 9.43
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.894B 17.20
Evotec AG (EVTCY) Germany $4.308B 46.24
Tilray (TLRY) Canada $4.300B 0.00
FibroGen (FGEN) United States $4.000B 0.00
United Therapeutics (UTHR) United States $3.338B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.172B 11.39
Arrowhead Pharmaceuticals (ARWR) United States $2.636B 397.14
PTC Therapeutics (PTCT) United States $2.549B 0.00
Xencor (XNCR) United States $2.481B 67.72
Zogenix (ZGNX) United States $2.005B 0.00
Portola Pharmaceuticals (PTLA) United States $1.776B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.687B 81.72
Enanta Pharmaceuticals (ENTA) United States $1.609B 21.99
Ironwood Pharmaceuticals (IRWD) United States $1.607B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.448B 0.00
USANA Health Sciences (USNA) United States $1.388B 12.06
Corcept Therapeutics (CORT) United States $1.223B 17.46
ArQule (ARQL) United States $1.162B 0.00
Aerie Pharmaceuticals (AERI) United States $1.159B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.048B 3.77
Radius Health (RDUS) United States $1.014B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.983B 0.00
Endo (ENDP) Ireland $0.893B 1.44
Spectrum Pharmaceuticals (SPPI) United States $0.887B 0.00
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.673B 0.00
Organogenesis Holdings (ORGO) United States $0.623B 0.00
TherapeuticsMD (TXMD) United States $0.598B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.580B 0.00
GlycoMimetics (GLYC) United States $0.555B 0.00
Karyopharm Therapeutics (KPTI) United States $0.511B 0.00
Akebia Therapeutics (AKBA) United States $0.503B 0.00
Translate Bio (TBIO) United States $0.499B 0.00
ChemoCentryx (CCXI) United States $0.479B 0.00
Siga Technologies (SIGA) United States $0.469B 1.11
Dermira (DERM) United States $0.462B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 23.19
Flexion Therapeutics (FLXN) United States $0.435B 0.00
CannTrust Holdings (CTST) Canada $0.432B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.420B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.420B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.407B 0.00
CV Sciences (CVSI) United States $0.405B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Indivior (INVVY) United States $0.393B 1.42
Collegium Pharmaceutical (COLL) United States $0.375B 0.00
ImmunoGen (IMGN) United States $0.371B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Xeris Pharmaceuticals (XERS) United States $0.322B 0.00
OptiNose (OPTN) United States $0.304B 0.00
Rafael Holdings (RFL) United States $0.299B 0.00
KalVista Pharmaceuticals (KALV) United States $0.293B 0.00
Concert Pharmaceuticals (CNCE) United States $0.272B 0.00
Molecular Templates (MTEM) United States $0.264B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.250B 0.00
Aratana Therapeutics (PETX) United States $0.248B 0.00
Lannett Co Inc (LCI) United States $0.229B 2.23
Ocular Therapeutix (OCUL) United States $0.227B 0.00
Recro Pharma (REPH) United States $0.225B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.211B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Calithera Biosciences (CALA) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
IMV INC (IMV) Canada $0.170B 0.00
Nature's Sunshine Products (NATR) United States $0.167B 54.00
Taiwan Liposome (TLC) Taiwan $0.164B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.150B 0.00
Jounce Therapeutics (JNCE) United States $0.141B 0.00
Majesco Entertainment (PTE) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.124B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.122B 0.00
AgeX Therapeutics (AGE) United States $0.113B 0.00
DURECT (DRRX) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
Infinity Pharmaceuticals (INFI) United States $0.096B 0.00
Capnia (SLNO) United States $0.095B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 63.89
MediWound (MDWD) Israel $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.083B 8.27
Avadel Pharmaceuticals (AVDL) Ireland $0.082B 0.00
Cardiome Pharma (CORV) Canada $0.080B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
China SXT Pharmaceuticals (SXTC) China $0.077B 0.00
Novan (NOVN) United States $0.075B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.060B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00